中国药用植物资源开发利用研究的回顾与展望

本文对药用植物资源开发的方法学进行了讨论,并简要综述了近年来我国在药用植物资源开发利用研究方面的成就,还就药用植物资源开发利用中的一些重要问题:生物多样性的保护;资源数据库的建立及管理;新技术和新方法的引进以及中药外向过程中资源的宏观调控管理等进行了讨论。     

Body Characteristics,Dietary Protein and Body Weight Regulation. Reconciling Conflicting Results from Intervention and Observational Studies?

Background/Objectives

Physiological evidence indicates that high-protein diets reduce caloric intake and increase thermogenic response, which may prevent weight gain and regain after weight loss. Clinical trials have shown such effects, whereas observational cohort studies suggest an association between greater protein intake and weight gain. In both types of studies the results are based on average weight changes, and show considerable diversity in both directions. This study investigates whether the discrepancy in the evidence could be due to recruitment of overweight and obese individuals into clinical trials.

Subjects/Methods

Data were available from the European Diet, Obesity and Genes (DiOGenes) post-weight-loss weight-maintenance trial and the Danish Diet, Cancer and Health (DCH) cohort. Participants of the DCH cohort were matched with participants from the DiOGenes trial on gender, diet, and body characteristics. Different subsets of the DCH-participants, comparable with the trial participants, were analyzed for weight maintenance according to the randomization status (high or low protein) of the matched trial participants.

Results

Trial participants were generally heavier, had larger waist circumference and larger fat mass than the participants in the entire DCH cohort. A better weight maintenance in the high-protein group compared to the low protein group was observed in the subgroups of the DCH cohort matching body characteristics of the trial participants.

Conclusion

This modified observational study, minimized the differences between the RCT and observational data with regard to dietary intake, participant characteristics and statistical analysis. Compared with low protein diet the high protein diet was associated with better weight maintenance when individuals with greater body mass index and waist circumference were analyzed. Selecting subsets of large-scale observational cohort studies with similar characteristics as participants in clinical trials may reconcile the otherwise conflicting results.     

Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges

Background

There is no agreed standard method to assess the efficacy of anti-malarials for uncomplicated falciparum in pregnancy despite an increased risk of adverse outcomes for the mother and the fetus. The aim of this review is to present the currently available evidence from both observational and interventional cohort studies on anti-malarial efficacy in pregnancy and summarize the variability of assessment and reporting found in the review process.

Methods

Efficacy methodology and assessment of artemisinin-based treatments (ABT) and quinine-based treatments (QBT) were reviewed systematically using seven databases and two clinical trial registries (protocol registration—PROSPERO: CRD42017054808). Pregnant women in all trimesters with parasitologically confirmed uncomplicated falciparum malaria were included irrespective of symptoms. This review attempted to re-calculate proportions of treatment success applying the same definition as the standard WHO methodology for non-pregnant populations. Aggregated data meta-analyses using data from randomized control trials (RCTs) comparing different treatments were performed by random effects model.

Results

A total of 48 eligible efficacy studies were identified including 7279 treated Plasmodium falciparum episodes. While polymerase chain reaction (PCR) was used in 24 studies for differentiating recurrence, the assessment and reporting of treatment efficacy was heterogeneous. When the same definition could be applied, PCR-corrected treatment failure of ≥ 10% at any time points was observed in 3/30 ABT and 3/7 QBT arms. Ten RCTs compared different combinations of ABT but there was a maximum of two published RCTs with PCR-corrected outcomes for each comparison. Five RCTs compared ABT and QBT. Overall, the risk of treatment failure was significantly lower in ABT than in QBT (risk ratio 0.22, 95% confidence interval 0.07–0.63), although the actual drug combinations and outcome endpoints were different. First trimester women were included in 12 studies none of which were RCTs of ABT.

Conclusions

Efficacy studies in pregnancy are not only limited in number but use varied methodological assessments. In five RCTs with comparable methodology, ABT resulted in higher efficacy than QBT in the second and third trimester of pregnancy. Individual patient data meta-analysis can include data from observational cohort studies and could overcome some of the limitations of the current assessment given the paucity of data in this vulnerable group.

     

江西珍稀濒危药用植物分级标准的研究

以江西省受威胁的３２种药用植物为研究对象,制定出江西省珍稀濒危药用植物保护的定量化分级标准。经过一系列评价标准的定量化及权得分配处理,以求得药用植物种的“濒危系数”和“Ｑ刀切保护值”,然后确定药用植物的受威胁程度和急切的保护的序列。     

miRNA调控药用植物生长发育和次生代谢

microRNA(miRNA)作为一类内源性的短链非编码RNA,广泛存在于真核细胞中,主要通过对转录本剪切和抑制翻译等方式,参与转录后基因的表达调控。近年来研究表明,多种药用植物中鉴定出大量的miRNA。这些miRNA对药用植物的生长发育和次生代谢产物合成具有调控功能。次生代谢产物是药用植物的主要有效成分,研究miRNA对药用植物次生代谢过程的调控作用具有十分重要的意义。本文综述了miRNA在植物中的产生途径、作用方式和体内功能,在此基础上重点介绍了miRNA对药用植物生长发育和次生代谢产物生物合成的调控作用,并对药用植物miRNA的研究进行了展望,以期为提高药用植物产量,高效获得药用植物有效成分以及临床应用开拓新的思路。     

Traditional Plants Used in Southern Brazil as a Source to Wound Healing Therapies

In southern Brazil, the biodiversity is great and the traditional use of medicinal plants for wound healing has been documented in ethnobotanical studies and pharmacological studies have assessed their wound properties and phytochemistry. Therefore, this study evaluated ethnobotanical surveys regarding medicinal plants used in southern Brazil for wound healing and studies about the healing properties of these plants published between 2000 and 2022. To retrieve articles related to the study, Web of Science, PubMed (NLM), Open Access Journals, Scielo, Lilacs, and Google Scholar, with keywords including medicinal plants, wound healing, and South of Brazil, have been used. As a result, 73 medicinal plants belonging to 39 families were found in ethnobotanical surveys as a traditional resource used for wound healing in southern Brazil, 15 of which were cited more than once. Besides, 14 of these 15 plants were also used as healing agents worldwide. The most cited plant with healing actions in southern Brazil was Symphytum officinale L. (comfrey). From 2000 to date, 44 articles scientifically demonstrated the wound-healing effects of the southern Brazilian plants found in ethnobotanical surveys reviewed. The folk medicine of southern Brazil presents a variety of medicinal plants for wound-healing purposes, and scientific data were found for some of those plants. However, the wound-healing properties of many plants have yet to be investigated, and the current literature still needs more phytochemical information about the plants studied. Aside from this, the future focus should be on the standardization of herbal extracts, and further research is required to investigate the pharmacological mechanisms. Clinical research in this area remains in its infancy and warrants more robust further clinical studies.     

MicroRNA与药用植物

MicroRNA（miRNA）是一类长度约为19～25个核苷酸的内源性非编码小分子单链RNA,对植物生长发育、次生代谢产物的生物合成以及抗逆性等有重要作用.近年来关于植物中miRNA的研究进展异常迅速,尤其是药用植物,目前已从一些药用植物中鉴定出miRNA,并分析了其在药用植物中的调控作用,这对药用植物的研究具有重要意义.本文综述了miRNA在植物中的产生途径、作用机制,同时重点介绍了miRNA在药用植物中的研究情况,使人们对药用植物中miRNA有更深的认识,为药用植物研究拓展新思路.     

樟芝的药用保健价值及开发应用(综述)

樟芝是一种原产于台湾的药用真菌,具有解毒抗癌、保肝强心、提高免疫力等功效。本文介绍樟芝的生物学特性、主要化学成分及药用保健价值,并对今后樟芝的开发应用提出建议。     

药用植物微生物组及其与药用植物次生代谢产物的关系

药用植物是中药的原料,是中药产业的源头,其生长发育受遗传和环境等诸多因素的影响。以往研究强调植物基因型及生态因子对药用植物产量和品质的影响。近几年,随着人类微生物组研究的推进,植物微生物组作为植物整体的重要组成部分在药用植物的生长发育、品质形成甚至药效等方面的作用也日益受到重视,有关植物微生物组的多样性,微生物组在植物生长发育中的作用已有较详细的综述,而有关药用植物微生物组及其与药用植物次生代谢产物间关系的综述较少。本文重点总结了自2010年以来药用植物微生物组的研究进展,包括药用植物微生物组物种组成、功能及其与药用植物次生代谢产物产生的关系等,并对其在药用植物提质增效及其生态种植中的潜在应用进行了展望。     

A database for anti-diabetic plants with clinical / experimental trials

A number of plants have been described in Ayurveda and other traditional medicine for the management of diabetes. However, information about them is not easily available. Active constituents of any medicinal plant define the efficacy and safety of treatment to control hyperglycemia. We describe the database to maintain the record of medicinal plants having anti-hyperglycemic or anti-diabetic activity. The database contains information such as plant name, its geographical distribution, useful plant part, known dosage, active constituents, mechanism of action and clinical/experimental data. The database also includes information about plant raw material suppliers or manufacturers in India. The current database includes 238 plants species and 123 Indian industries using them. AVAILABILITY: The database is freely available at http://www.biotechpark.org.in/antidia/index.html.     

广西靖西端午节药市民族药用植物数据库系统的设计与构建

药用植物数据库的建立与相关数据挖掘,对民族药物学的研究具有重要意义。该研究在顶层设计的基础上,对广西靖西端午节药市及周边地区实地调查时获得的药用植物标本和照片进行形态学特征、药用价值、民族传统利用方式等信息的整理,由此设计和建立开放的民族药用植物数据库系统。主要应用Microsoft Office Access和Java编程对数据进行管理、查询和统计,通过提取药用植物特征的不同权值来计算不同科属和类别之间的相似度。结果表明:该数据库系统能以柱状图或饼状图的形式将数据之间的关系直观地展示出来,从而反映出各种植物特征和各种功能属性之间的联系。同时该数据库系统还可以用于数据的管理、检索和查询相关民族药用植物的背景资料、药用价值等信息,并能进行相应的统计分析,有利于挖掘数据和发现新线索。     

Somatic embryogenesis and high frequency plantlet regeneration in callus cultures ofThevetia peruviana

Plantlet regeneration through somatic embryogenesis has been achieved in the apocynaceous medicinal treeThevetia peruviana L. Calluses obtained by culturing young leaf discs on MS medium containing 9 M 2,4-dichlorophenoxyacetic acid and 4.6 M kinetin, when subjected to reduced levels of the growth regulators followed by higher cytokinin treatment, produced numerous somatic embryos. Somatic embryos developed into complete plantlets on a medium devoid of growth regulators. An average of 40–50 plantlets were obtained from 50 mg of embryogenic callus. Survival of transplants was 60% under glasshouse conditions.     

金线莲研究进展(综述)

本文对珍稀中草药金线莲的生物学特性、资源分布、药用价值、成分分析、生理活性、细胞学、分子生物学、组织培养及栽培技术等方面作了综述,为深入研究和合理开发利用金线莲提供参考。     

中国药用真菌名录及部分名称的修订

近年来,我国对药用真菌的研究和利用越来越重视,相关报道逐年增加。针对有些种类鉴定有误、拉丁学名使用没有严格遵守最新国际植物命名法规、命名人缩写不规范等问题,作者系统考证了我国药用真菌的名称,共收录473种,对每种名称按新近的研究成果和最新命名法规(维也纳法规)进行了订正,对过去的错误报道或不存在的名称进行了修正,将曾报道的、但应作为其他种的同物异名者列在其正名之后,所有名称定名人的缩写全部按国际植物命名法规的要求加以规范化。每种名称之后还列举了该种的主要药用功能或价值,并引证了主要参考文献。     

浙江新昌县药用植物资源研究

对浙江新昌县植物资源作了系统调查。经鉴定并根据已掌握的资料,新昌县有药用维管植物155科 504属807种,其中蕨类植物20科34属51种,种子植物135科470属756种。按其药用功能划分成清热药、 解表药等十类,并对每一类的药用功能作了详细介绍。进一步发现在新昌药用植物中有22种属于国家级或 省级珍稀植物。最后对新昌县药用植物资源的保护和持续利用提出了建议。     

Tradicional use of medicinal plants with diuretic properties at Quemado de Güines Municipality, Cuba

Medicinal plants are highly rich in Cuba and an amount of 179 species have been reported to be used by the population for diuretic purposes, nevertheless, no experimental validation has supported this effect. This study presents the relative importance of the medicinal plant species most widely used for diuretic purposes in two communities of Quemado de Guines Municipality, Villa Clara province. The information was obtained through the application of an interview to 85 inhabitants, from which 80 were random surveys to people with a great knowledge of plants, and five to herbalists and doctors practicing natural medicine. The etnopharmacological information was registered (gathered) by means of the "Tradicional of the Medicine of the Island" (TRAMIL) methodology and the interesting species were identified by a botanist and deposited in the Herbarium of the Central University "Marta Abreu" from Villa Clara, registered in the Index Herbarium, published periodically by the International Association for Plant Taxonomy. The data was analyzed by means of the indexes of use values and significant use level after TRAMIL. From the total of 19 botanical families, 26 medicinal species were identified, and 10 plants resulted with higher significant use and higher indexes of use values. From the plants reported as diuretics, 53.8% have not been experimentally validated in Cuba, the rest of the identified species have been validated at a preclinical level in some centers in the country, but its use have not been authorized as phytochemicals by the Cuban Regulatory Agency. The documentation related to the use of medicinal plants in the studied areas reveals that the traditional knowledge continues deeply rooted in the communities, and popular wisdom is kept through the representative images of the herbalist and people with considerable knowledge about this topic.     

安徽省老鸦瓣属药用植物资源

目的:研究安徽省老鸦瓣属药用植物资源分布和开发利用情况。方法:野外实地调查、标本采集鉴定、文献资料查阅。结果:安徽省老鸦瓣属药用植物有4种,皆可药用,发现1个新分类群有待进一步研究。结论:为今后深入研究利用安徽省老鸦瓣药用植物资源提供科学依据。     

食药用真菌多糖对肿瘤免疫逃逸调节作用机制研究进展

食药用真菌多糖是食药用真菌的主要天然生物活性成分,可以从多层次、多靶点调节机体的免疫功能,被认为是一种天然免疫调节剂。此前食药用真菌多糖抗肿瘤机制研究集中在提升机体的免疫力达到抑制肿瘤的目的,但近年的研究表明它可以调节肿瘤微环境,恢复机体对肿瘤以及肿瘤微环境的监视能力,提升机体对肿瘤微环境的特异性免疫应答能力,进而达到充分发挥其抑制和杀伤肿瘤的功能。我们课题组前期研究中也发现食药用菌多糖可以正向调节肿瘤小鼠外周血免疫细胞数量,促进免疫细胞浸润到肿瘤微环境中帮助机体识别及杀伤肿瘤细胞,改善肿瘤微环境免疫状态。本文在我们团队的研究工作的基础上,结合国内外文献总结食药用真菌多糖作为免疫调节剂在抑制肿瘤免疫逃逸中的生物活性,结合肿瘤微环境探讨其与肿瘤免疫的关系、作用机制和在肿瘤治疗中的作用,以期为食药用真菌多糖免疫治疗提供新思路。     

Using Highly Detailed Administrative Data to Predict Pneumonia Mortality

Background

Mortality prediction models generally require clinical data or are derived from information coded at discharge, limiting adjustment for presenting severity of illness in observational studies using administrative data.

Objectives

To develop and validate a mortality prediction model using administrative data available in the first 2 hospital days.

Research Design

After dividing the dataset into derivation and validation sets, we created a hierarchical generalized linear mortality model that included patient demographics, comorbidities, medications, therapies, and diagnostic tests administered in the first 2 hospital days. We then applied the model to the validation set.

Subjects

Patients aged ≥18 years admitted with pneumonia between July 2007 and June 2010 to 347 hospitals in Premier, Inc.’s Perspective database.

Measures

In hospital mortality.

Results

The derivation cohort included 200,870 patients and the validation cohort had 50,037. Mortality was 7.2%. In the multivariable model, 3 demographic factors, 25 comorbidities, 41 medications, 7 diagnostic tests, and 9 treatments were associated with mortality. Factors that were most strongly associated with mortality included receipt of vasopressors, non-invasive ventilation, and bicarbonate. The model had a c-statistic of 0.85 in both cohorts. In the validation cohort, deciles of predicted risk ranged from 0.3% to 34.3% with observed risk over the same deciles from 0.1% to 33.7%.

Conclusions

A mortality model based on detailed administrative data available in the first 2 hospital days had good discrimination and calibration. The model compares favorably to clinically based prediction models and may be useful in observational studies when clinical data are not available.